Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995; 81(6): 935-946.
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995; 268(5215): 1347-1349.
(1995)Science., vol.268, Issue.5215, pp. 1347-1349
Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia
Rensing-Ehl A, Janda A, Lorenz MR, et al. Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia. Haematologica. 2013; 98(12): 1948-1955.
NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet a-granules
Gunay-Aygun M, Falik-Zaccai TC, Vilboux T, et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet a-granules. Nat Genet. 2011; 43(8): 732-734.
Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome
Albers CA, Cvejic A, Favier R, et al. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat Genet. 2011; 43(8): 735-737.
Gray platelet syndrome: Natural history of a large patient cohort and locus assignment to chromosome 3p
Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, et al. Gray platelet syndrome: Natural history of a large patient cohort and locus assignment to chromosome 3p. Blood. 2010; 116(23): 4990-5001.
FAS-L IL-10 and double-negative CD4-CD8-TCR a/b1 T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function
Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, et al. FAS-L, IL-10, and double-negative CD4-CD8-TCR a/b1 T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood. 2009; 113(13): 3027-3030.
Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome
Caminha I, Fleisher TA, Hornung RL, et al. Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome. J Allergy Clin Immunol. 2010; 125(4): 946-949.e6.